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This report presents the main findings from an interna-
tional workshop on Shiga toxin-producing Escherichia 
coli (STEC), held on 28–29 November 2011, organised 
by the Robert Koch Institute [1]. The workshop assem-
bled over 100 experts in clinical medicine, epidemi-
ology, public health, microbiology, food safety, and 
environmental science from various countries.
The 2011 outbreak
From May to July 2011, Germany experienced an unprec-
edented outbreak of bloody diarrhoea and haemolytic 
uraemic syndrome (HUS) mostly among previously 
healthy adults caused by STEC serotype O104:H4 [2-4]. 
Travellers from several countries were affected and an 
autochthonous outbreak caused by the same strain 
occurred in France [5]. Fenugreek sprouts were identi-
fied as the vehicle of infection [6].
Although the outbreak was controlled successfully, 
significant scientific challenges remain. To address 
these challenges, the workshop organised four work-
ing groups to discuss research needs in the following 
areas: (i) clinical issues, (ii) epidemiology, prevention 
and burden of disease, (iii) microbiology and patho-
genesis and (iv) food safety, zoonotic and environmen-
tal aspects. The major research needs are presented 
below.
Clinical issues
As an important characteristic of the outbreak, many 
patients experienced severe clinical symptoms, and 
case fatality was substantial. Almost 50% of the HUS 
patients needed dialysis and a similar proportion 
developed neurologic symptoms [7]. Meanwhile, the 
vast majority of patients have completely recovered. 
No causal therapy for HUS exists, and pooled analysis 
of previous data showed no benefit of antibiotic treat-
ment. In this outbreak, novel strategies for treating 
patients with HUS were applied (eg, antibody treat-
ment with Eculizumab, immunoadsorption). The overall 
goal should be to optimise early diagnosis and care for 
patients with STEC-associated disease to reduce mor-
tality and prevent organ damage.
Disease course and outcome: 
manifestations and predictors
The natural disease course including the overall fre-
quency and severity of the involvement of different 
organ systems should be investigated. Another aim 
is to study the risk factors and protective factors for 
the development of the different stages of STEC dis-
ease such as. bloody diarrhoea, HUS, neurological 
symptoms, recovery, and fatal outcome. This should 
include demographic and clinical characteristics, as 
well as genetic and environmental factors. Appropriate 
biomarkers (e.g. complement activation, chemokines, 
cytokines) indicating the risk of severe disease should 
be determined. Risk scores should be developed to 
identify and adequately treat patients at increased 
risk of HUS. The available clinical data could be used 
to develop an algorithm for standardised diagnostic 
procedures. The pathogenetic mechanisms underlying 
severe organ-specific lesions and recovery should be 
investigated (e.g. kidney, central nervous system).
Effectiveness and safety of treatment strategies
This outbreak provides a unique opportunity to study 
the effects of antibiotics on the disease course. The 
effectiveness and safety of antibody treatment and 
immunoadsorption (short and long term outcomes) 
should be studied. Moreover, new therapeutic strate-
gies to effectively remove Shiga toxin from the gas-
trointestinal tract once STEC has been diagnosed 
should be developed. Based on the scientific data 
obtained in this outbreak, recommendations for the 
future use of new and already existing therapeutic 
measures and international study protocols for treat-
ment of STEC-HUS are warranted.
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Epidemiology, prevention 
and burden of disease
Research questions were collected and categorised 
according to high, moderate or low priority. Some 
areas may not belong to epidemiologic research in a 
stricter sense, but relate primarily to improving out-
break detection and control and STEC surveillance. The 
four topics outlined in the sections below were consid-
ered of utmost importance.
Laboratory surveillance for outbreak detection
Research should be targeted towards developing an 
optimal strategy for STEC surveillance. Diagnosis of all 
STEC is complex, but it is paramount to have a scheme 
allowing for timely assessment of the virulence profile 
of the causative agents and other characteristics (e.g. 
serotype) facilitating basic identification of clusters or 
of strains amenable for further subtyping (e.g. O157). 
The usefulness of improved microbiological methods 
for primary detection of STEC and other diarrhoeagenic 
E.  coli for clinical and public health purposes should 
be studied. Molecular subtyping is a powerful tool for 
detecting and investigating food-borne outbreaks, and 
its implementation is recommended. Research should 
identify the most useful typing methods and evaluate 
its cost-effectiveness.
Product-tracing investigations 
as an epidemiological tool
The STEC O104:H4 outbreak exemplified the value of 
product tracing investigations to identify suspected 
foods in outbreaks (e.g. by linking tracing information 
to disease clusters). Although successfully applied pre-
viously, the methodology is used infrequently thus far. 
Furthermore, it should be applied as an epidemiologi-
cal tool for incriminating (or exonerating) suspected 
food items in outbreaks. It should be further devel-
oped and standardised as a tool in analytical epidemi-
ological investigations. In this context it is necessary 
that legislation for public health or food safety allows 
for efficient usage of the methodology in food-borne 
outbreaks.
Economic costs of the outbreak 
/ Burden of illness
This outbreak was unprecedented with respect to the 
number of HUS cases. Patient treatment is expen-
sive (and long-term consequences are apprehended). 
Moreover, the outbreak led to costly trade-bans. 
Similarly, the burden of infectious intestinal diseases 
in general is substantial. Little is known about the 
overall burden of these infections, the contribution of 
the different pathogens to this burden, and the path-
ogen-specific risk factors. Estimating the costs of this 
outbreak and of infectious intestinal disease in gen-
eral (e.g. disability adjusted life years, modelling) is 
pivotal to guide decision makers in rationally allocat-
ing financial resources for research and surveillance 
of infectious diseases. Population-based data on the 
pathogen-specific gastrointestinal disease burden are 
needed to improve targeted prevention and control 
measures.
Clinical epidemiology
The risk factors for the short-term and the long-term 
outcome in patient cohorts should be studied. Another 
research topic is the frequency and determinants of 
secondary transmission (households etc.) of STEC 
O104:H4 and other serotypes.
Microbiology and pathogenesis
This outbreak vividly demonstrated the need to rap-
idly detect and molecularly characterise emerging 
STEC pathogens. Pathogenesis and evolution of STEC-
mediated HUS are incompletely understood.
Microbiological diagnosis
Rapid and innovative methods facilitating early diag-
nosis of STEC (including emerging strains) should be 
established. Such approaches should combine molec-
ular detection, culture and isolation of the pathogen 
and improve both outbreak detection and control and 
patient management. Methods to type and character-
ise such pathogens need to be improved. This requires 
the most advanced sequencing and data management 
capacities. It is a priority to implement molecular 
surveillance of STEC, including a central global data-
base, analogous to PulseNet [8], containing typing 
and virulence data from human STEC isolates linked 
to STEC databases for animals, food and environment. 
Methods to detect viable but non-culturable STEC 
should be improved. It is important to optimise patient 
management via symptom-based approaches in order 
to accelerate diagnosis, implement best clinical and 
infection control practices, and to detect outbreaks as 
early as possible. Determining the duration of patho-
gen shedding by patients and quantifying the number 
of asymptomatic shedders is critical for epidemiologi-
cal purposes. This should also include enteroaggrega-
tive E. coli (EAEC) and other diarrhoeagenic E. coli.
Pathogenesis and evolution
More evidence is needed on virulence and fitness 
factors of STEC, and on the mechanisms of their 
interaction with the host cells and their targets. In par-
ticular the roles of Shiga toxins and other toxins, ser-
ine proteases, and adhesins, iron uptake systems and 
growth-promoting factors expressed by these organ-
isms should be delineated. Resistance of STEC to envi-
ronmental stress, and the environmental factors that 
promote genetic changes in and spread of STEC viru-
lence factors should be studied (role of phages, plas-
mids, and other mobile genetic elements). Infection 
models to study virulence and fitness under different 
conditions should be refined. Novel host and microbe 
targets for therapy have to be identified. Another 
research question relates to the protective host mecha-
nisms including immune response and the role of com-
mensal microbiota. The phylogenetic origin of STEC 
and their recent evolutionary emergence should be 
determined. The reservoirs, vectors and transmission 
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of STEC and other diarrhoeagenic E. coli warrant fur-
ther investigation.
Antimicrobial therapy
A major objective is to determine the effect of antimicro-
bials on stx-phage induction, Shiga toxin production, 
virulence and resistance gene transfer, and intestinal 
adherence (in vitro and in animal models). The mecha-
nisms of transfer of antimicrobial resistance, for exam-
ple extended-spectrum beta-lactamase, via plasmids 
in response to variable selective pressures should 
be delineated. The role of biofilm formation in STEC 
antimicrobial resistance and niche persistence during 
infection and in the environment should be studied, 
and the role of antimicrobial therapy in shortening bac-
terial shedding should be determined.
Food safety, zoonotic and 
environmental aspects
Food safety
Optimised detection methods are needed for investi-
gations of survival and multiplication of STEC O104:H4 
and other STEC in food matrices including fruits and 
vegetables. Research should be dedicated to the trac-
ing of trading connections. Information systems pro-
viding real-time information from different market 
segments and incorporating the identification of risk 
factors as well as elements of predictive microbiology 
should be implemented. Risk profiling and ranking of 
combinations of foodstuffs and pathogens should be 
conducted (based on criteria such as microbiology, 
food processing and consumption, infectious dose, 
burden of disease). This will allow to identify the opti-
mal sampling and control points along the food chain 
as well as the most efficient processing steps for 
decontamination based on hazard analysis and criti-
cal control points (HACCP). Decontamination methods 
for different types of foodstuff should be investigated. 
These should also take into consideration microbio-
logical characteristics such as biofilm formation.
Zoonotic aspects
Controlled infection experiments with various animal 
species may provide information about the potential 
of STEC O104:H4 to cross the species barrier from 
humans to animals and to establish itself in livestock, 
wild or pet animals. Studies in animals putatively 
exposed to STEC O104:H4 during the outbreak or sub-
sequently should elucidate whether the pathogen has 
already spread to animals and is maintained in animal 
populations.
Reducing faecal STEC shedding and lowering its preva-
lence in livestock are promising strategies to protect 
humans from zoonotic STEC infection. Research is 
needed to understand host factors that predispose 
ruminants to STEC infection and shedding such as 
innate and acquired immunity, intestinal microbiota, 
genetic background and extrinsic factors such as live-
stock production systems. Innovative immunisation 
schemes as well as novel diets and pre- and probiotics 
against intestinal STEC colonisation in ruminants 
should be investigated.
Environmental aspects
The risks for products of animal and plant origin 
becoming contaminated by STEC originating from 
environmental sources such as soil, water, sewage 
systems, waste, human and animal shedding should 
be assessed. Laboratory studies and predictive micro-
biology may be used for the investigation of survival 
and multiplication of STEC in different microenviron-
ments, also accounting for possible biofilm formation. 
Improved sampling and detection methods for environ-
mental samples should be developed. The distribution 
of environmental STEC should be investigated along 
the food production chain as well as the horizontal 
transfer of virulence and antibiotic resistance genes 
between E. coli and other bacteria in these habitats.
Research should address the issue of selective pres-
sure by environmental or management factors con-
tributing to the development of niches facilitating the 
survival or multiplication of STEC and the emergence of 
new E. coli seropathotypes. Decontamination methods 
for waste water, surface waters and production water 
such as water used for the irrigation of plants should 
be assessed.
Conclusions
This massive outbreak had substantial international 
implications. It exemplified that the landscape of 
food-borne infections is in flux, that multi-national 
outbreaks are a reality and that they can occur every-
where, irrespective of food safety standards.
The workshop showed that urgent and challenging 
research needs exist in the field of STEC and other 
diarrhoeagenic E.  coli, and as far as burden of illness 
is concerned also of other food-borne pathogens. The 
scientific questions identified need to be further priori-
tised and strategies to address them should be devel-
oped. The workshop delineated interfaces between the 
working groups. Among those, the most notable are (i) 
the need to further develop diagnostic methods and to 
integrate molecular typing into routine surveillance, 
(ii) to study the pathogenesis, clinical course and new 
treatment options, (iii) to make use of systematic food 
tracing data as epidemiological tools, and (iv) to study 
pathogen evolution among the human host, the envi-
ronment, and in animal reservoirs.
These research needs must be addressed soon in 
order to better equip clinicians, microbiologists, public 
health and food safety authorities for the early detec-
tion and efficient control of food-borne outbreaks and 
to prevent similar events. As it is an obligation of the 
scientific community to investigate these research 
questions it is also in the responsibility of national and 




The workshop was funded by the Ministry of Health, 
Germany.
Members of the STEC Workshop Reporting Group in al-
phabetical order:
Corresponding author: K Stark (starkk@rki.de), Robert Koch 
Institute, Berlin, Germany, R Bauerfeind, Institute for Hygiene 
and Infectious Diseases of Animals, Justus Liebig University 
Giessen, Giessen, Germany, H Bernard, Robert Koch Institute, 
Berlin, Germany, T Eckmanns, Robert Koch Institute, Berlin, 
Germany, S Ethelberg, Statens Serum Institut, Copenhagen, 
Denmark, A Flieger, Robert Koch Institute, Berlin, Germany, 
J Giesecke, European Centre for Disease Prevention and 
Control (ECDC), Stockholm, Sweden, M Greiner, Federal 
Institute of Risk Assessment, Berlin, Germany, H Karch, 
Institute of Hygiene, University Münster, Münster, Germany, 
G Krause, Robert Koch Institute, Berlin, Germany, M 
Mielke, Robert Koch Institute, Berlin, Germany , SJ O’Brien, 
Institute of Infection and Global Health, National Centre for 
Zoonosis Research, University of Liverpool, United Kingdom, 
M Pulz, State Authority for Public Health Lower Saxony, 
Hannover, Germany, F Scheutz, Statens Serum Institut, 
Copenhagen, Denmark, A Schielke, Robert Koch Institute, 
Berlin, Germany, RA Stahl, Department of Medicine, Division 
of Nephrology, University Hospital Hamburg-Eppendorf, 
Hamburg, Germany, J Takkinen, European Centre for Disease 
Prevention and Control (ECDC), Stockholm, Sweden, PI Tarr, 
Department of Pediatrics, Division of Gastroenterology and 
Nutrition, Washington University in St. Louis, United States, 
RV Tauxe,  Centers for Disease Control and Prevention (CDC), 
Atlanta, United States, D Werber, Robert Koch Institute, 
Berlin, Germany.
References
1. International Workshop ’Experiences from the STEC O104:H4 
outbreak in Germany and research needs for STEC‘, 28–29 
November 2011, Berlin, Germany.
2. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der 
Heiden M, et al. Epidemic profile of Shiga-toxin-producing 
Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 
2011;365(19):1771-80.
3. Frank C, Faber MS, Askar M, Bernard H, Fruth A, Gilsdorf A, 
et al. Large and ongoing outbreak of haemolytic uraemic 
syndrome, Germany, May 2011. Euro Surveill. 2011;16(21). 
pii: 19878. Available from: http://www.eurosurveillance.org/
ViewArticle.aspx?ArticleId=19878
4. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, 
Bauwens A, et al. Characterisation of the Escherichia coli 
strain associated with an outbreak of haemolytic uraemic 
syndrome in Germany, 2011: a microbiological study. Lancet 
Infect Dis. 2011;11(9):671-6.
5. Gault G, Weill FX, Mariani-Kurkdjian P, Jourdan-da Silva N, King 
L, Aldabe B, et al. Outbreak of haemolytic uraemic syndrome 
and bloody diarrhoea due to Escherichia coli O104:H4, south-
west France, June 2011. Euro Surveill. 2011;16(26). pii: 19905. 
Available from: http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=19905
6. Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, 
Wilking H, et al. German outbreak of Escherichia coli O104:H4 
associated with sprouts. N Engl J Med. 2011;365(19):1763-70.
7. Stahl RA. Eculizumab in STEC-HUS. Presented at the 44th 
Meeting of the American Society of Nephrology, November 
8–13, 2011, Philadelphia, USA.
8. Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV; CDC PulseNet 
Task Force. PulseNet: the molecular subtyping network for 
foodborne bacterial disease surveillance, United States. Emerg 
Infect Dis. 2001;7(3):382-9.
